Whitepapers & Special Reports

5 Ways to Improve Spirometry Quality in a Clinical Trial
In the experience of the authors of this review, a significant portion of spirometry data in clinical trials is of inadequate or questionable quality. The aim of this whitepaper is to describe and explain the main quality issues encountered in clinical trials whilst exploring mitigation actions that reduces these issues.

Whitepapers & Special Reports Archive
Reducing the Risks inherent in Emergency medical Contact and Unblinding
All sides agree that patient safety is paramount in the conduct of clinical trials. While focused on patient safety, investigators and sponsors are also mindful of the need to maintain study integrity, to the extent possible.
De-Identification 101
Big data and big privacy can go together. Safely and securely share health data information with the right strategy: de-identification. Learn everything there is to know about the process in Privacy Analytics’ white paper. De-identification takes data-masking to a whole new place–ensuring quality, granular data while minimizing risk of data breach and re-identification. HIPAA compliant, de-identification goes even further to protect sensitive information while maintaining data utility for secondary purposes.
How to Safeguard for PHI
Context is king when it comes to safeguarding Protected Health Information (PHI). As patients, we share many personal details with our care providers. Concerns over who has access to this information and how it may be used can cause us as much worry as our health issues. Effectively safeguarding PHI means knowing who will have access to the data, how it will be stored and what details it contains. In other words, its context for use.
Leveraging the Force - How Social, Mobile, Analytics and Cloud Technologies Are Optimizing Clinical Development
How can the biopharmaceutical industry leverage progressive technology concepts by adopting emerging digital technologies such as social media, mobile, analytics and cloud (SMAC) to optimize the drug development process? This article explores how evolving digital technologies combined with key clinical advancements can optimize the clinical development process.
Part One: Taming Technology Chaos, A Vision of eClinical’s Future
For more than a decade eClinical technologies have been steadily transforming clinical trials for the better. Yet despite delivering improved trial efficiency, the proliferation of diverse tools – clinical trial management systems (CTMS), randomization and trial supply management (RTSM), and electronic data capture (EDC) to name just a few – has also produced a ‘technology chaos’ as users and vendors struggle to knit the new tools into comprehensive solutions. To a large extent this isn’t surprising. Technology adoption across most industries, especially operational technologies, follows a similar pattern.

Recent whitepapers include:

 

Perceptive Informatics logo     From Convergence Vision to Reality
Persistent logo     Bridging the gap between compliance and innovation
Novella Clinical logo     Global Oncology Trials: Planning For Success
OpenText logo     Comply or Perish: Maintaining 21 CFR Part 11 Compliance

 

Sapio logo

    Laboratory Management for Clinical and Research NGS Labs

 Novella Clinical logo
     Optimizing Early Phase Oncology Clinical Trials
 Perceptive Informatics logo
     Unlocking the Value of Observational Research.  Cutting Costs, Saving Time:
     Improving Life Sciences Operations with Digital Signatures
 
      

 


To promote your whitepaper with Clinical Informatics, please contact:   

 

Angela Parsons
VP, Business Development 
Tel: 781-972-5467 

 

 

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.